Aditya Birla Sun Life Pharma & Healthcare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 9 Nov 2026
- ₹37.20+1.92%1 day
- Return since launch
- 19.3%
- 52-week range
- ₹29.27 — ₹37.00
- AUM
- ₹1,088 Cr
Aditya Birla Sun Life Pharma & Healthcare Fund is a Sectoral-Pharma equity fund from Aditya Birla Sun Life Mutual Fund with ₹1,088 Cr under management, launched in 2019. Over three years it has returned 15.3% a year, against 21.2% for its category. The expense ratio is 2.29% and the SEBI riskometer reading is Very High.
Performance
Aditya Birla Sun Life Pharma & Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +19.6% against +19.9% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 26.1% | +5.3 pts | 20.8% | 29.1% |
| 2Y | 17.2% | −1.8 pts | 19.1% | 17.6% |
| 3Y | 15.3% | −5.9 pts | 21.2% | 16.0% |
| 5Y | 18.4% | +3.0 pts | 15.4% | 18.5% |
| 7Y | 17.6% | −1.3 pts | 18.9% | 18.0% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 7.4% | −1.0 pts | 8.4% | 8.5% |
| 3M | 1.4% | −2.3 pts | 3.7% | 3.7% |
| 6M | 11.6% | −2.4 pts | 14.0% | 13.6% |
| 1Y | 19.4% | −1.4 pts | 20.8% | 19.4% |
| 2Y | 9.9% | −0.9 pts | 10.8% | 9.5% |
| 3Y | 19.4% | −1.9 pts | 21.2% | 20.0% |
| 5Y | 14.3% | −1.1 pts | 15.4% | 14.6% |
| 7Y | 20.0% | −2.4 pts | 22.4% | 21.2% |
Since launch (20 Jun 2019): 19.3%
Calendar-year returns
Category average53.8%
19.5%
-12.7%
37.7%
35.5%
-4.3%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -4.3% | −2.3 pts | -2.0% |
| 2024 | 35.5% | −5.4 pts | 40.9% |
| 2023 | 37.7% | +1.4 pts | 36.2% |
| 2022 | -12.7% | −4.4 pts | -8.3% |
| 2021 | 19.5% | −2.2 pts | 21.7% |
| 2020 | 53.8% | −15.0 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.28%
Expense ratio as on 5 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.89%
- Brokerage
- 0.03%
- Transaction charges
- 0.00%
- Statutory levies
- 0.36%
- Exit load
- Exit load of 1% if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -1.60 | 1.49 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.91 | 0.94 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.89 | 1.10 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.57 | 1.81 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 15.30 | 15.62 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
Aditya Birla Sun Life Pharma & Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity97.9%
- Other2.1%
Market cap split
- Large33.6%
- Mid32.4%
- Small34.0%
- P/E
- 40.49
- P/B
- 5.64
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | Healthcare | 9.28% | ₹99.97 Cr | +4.68% | +5.03% | +4.45% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 8.61% | ₹92.79 Cr | +12.09% | +13.42% | +11.17% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 6.44% | ₹69.35 Cr | +7.30% | +7.34% | +7.59% |
| Cipla Ltd. | Healthcare | 6.38% | ₹68.71 Cr | +2.93% | +3.24% | +6.83% |
| Aurobindo Pharma Ltd. | Healthcare | 4.52% | ₹48.70 Cr | +4.55% | +4.42% | +2.89% |
| Sai Life Sciences Ltd. | Healthcare | 4.49% | ₹48.36 Cr | +3.50% | +2.09% | +1.92% |
| Ajanta Pharma Ltd. | Healthcare | 4.35% | ₹46.82 Cr | +4.38% | +4.22% | +3.75% |
| Mankind Pharma Ltd. | Healthcare | 3.62% | ₹38.95 Cr | +3.92% | +2.93% | +2.95% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 3.51% | ₹37.77 Cr | +1.59% | — | — |
| Abbott India Ltd. | Healthcare | 3.26% | ₹35.08 Cr | +3.26% | +3.90% | +4.57% |
| Emcure Pharmaceuticals Ltd. | Healthcare | 3.21% | ₹34.54 Cr | +3.23% | +3.30% | +2.74% |
| Lupin Ltd. | Healthcare | 2.94% | ₹31.71 Cr | +3.74% | +4.21% | +4.52% |
| Ipca Laboratories Ltd. | Healthcare | 2.71% | ₹29.20 Cr | +2.55% | +4.11% | +3.55% |
| Gland Pharma Ltd. | Healthcare | 2.70% | ₹29.14 Cr | +2.48% | +0.99% | +1.20% |
| Fortis Healthcare Ltd. | Healthcare | 2.42% | ₹26.10 Cr | +3.21% | +3.49% | +5.58% |
| CORONA Remedies Ltd. | Healthcare | 2.27% | ₹24.49 Cr | +2.28% | +2.12% | — |
| Divi's Laboratories Ltd. | Healthcare | 2.24% | ₹24.16 Cr | +1.69% | +1.80% | +1.78% |
| Others | Others | 2.06% | ₹22.21 Cr | -0.22% | +0.35% | -0.48% |
| Procter & Gamble Health Ltd. | Healthcare | 1.82% | ₹19.58 Cr | +2.20% | +1.97% | +1.44% |
| Thyrocare Technologies Ltd. | Healthcare | 1.76% | ₹18.94 Cr | +1.93% | +1.44% | +1.93% |
| Alkem Laboratories Ltd. | Healthcare | 1.68% | ₹18.09 Cr | +1.93% | +2.16% | +2.29% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.55% | ₹16.66 Cr | +1.85% | +1.96% | +2.41% |
| Metropolis Healthcare Ltd. | Healthcare | 1.48% | ₹15.91 Cr | +1.44% | +1.36% | +1.65% |
| Biocon Ltd. | Healthcare | 1.45% | ₹15.63 Cr | +1.12% | +1.14% | +1.12% |
| Shilpa Medicare Ltd. | Healthcare | 1.43% | ₹15.39 Cr | +2.41% | +2.26% | +1.03% |
| Piramal Pharma Ltd. | Healthcare | 1.22% | ₹13.18 Cr | +1.06% | +0.92% | +1.01% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 1.13% | ₹12.20 Cr | +1.33% | +1.45% | +1.46% |
| Anthem Biosciences Ltd. | Healthcare | 1.13% | ₹12.17 Cr | +1.08% | +1.08% | +3.22% |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 1.11% | ₹12.00 Cr | +1.44% | +1.58% | +1.09% |
| Suraksha Diagnostic Ltd. | Healthcare | 1.10% | ₹11.90 Cr | +0.90% | +0.89% | +1.20% |
| Manipal Health Enterprises Ltd. | Healthcare | 1.07% | ₹11.50 Cr | — | — | — |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 1.04% | ₹11.24 Cr | +1.05% | +0.78% | +0.94% |
| Pfizer Ltd. | Healthcare | 1.01% | ₹10.87 Cr | +1.23% | +1.40% | +1.00% |
| Natco Pharma Ltd. | Healthcare | 0.92% | ₹9.93 Cr | — | — | — |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 0.83% | ₹8.97 Cr | +0.79% | +0.87% | +1.31% |
| Medi Assist Healthcare Services Ltd. | Services | 0.73% | ₹7.90 Cr | +0.95% | +0.90% | +1.64% |
| Vinati Organics Ltd. | Chemicals | 0.69% | ₹7.47 Cr | +0.85% | +0.73% | +0.99% |
| Syngene International Ltd. | Healthcare | 0.64% | ₹6.91 Cr | +0.82% | — | — |
| Max Healthcare Institute Ltd. | Healthcare | 0.60% | ₹6.51 Cr | +0.78% | +0.78% | +0.94% |
| Jubilant Pharmova Ltd. | Healthcare | 0.60% | ₹6.49 Cr | +0.61% | +1.11% | +1.23% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Dr. Lal Pathlabs Ltd. | 2.10% | 3.51% | +1.40% |
| Cipla Ltd. | 5.16% | 6.38% | +1.21% |
| Others | -0.25% | -0.85% | -0.60% |
| Sun Pharmaceutical Industries Ltd. | 9.19% | 8.61% | -0.58% |
| Apollo Hospitals Enterprise Ltd. | 6.85% | 6.44% | -0.42% |
| Fortis Healthcare Ltd. | 2.79% | 2.42% | -0.37% |
| Torrent Pharmaceuticals Ltd. | 9.57% | 9.28% | -0.29% |
| Sai Life Sciences Ltd. | 4.20% | 4.49% | +0.29% |
| Biocon Ltd. | 1.19% | 1.45% | +0.27% |
| Abbott India Ltd. | 3.03% | 3.26% | +0.22% |
| Jupiter Life Line Hospitals Ltd. | 1.76% | 1.55% | -0.21% |
| Emcure Pharmaceuticals Ltd. | 2.99% | 3.21% | +0.21% |
| Mankind Pharma Ltd. | 3.41% | 3.62% | +0.20% |
| Thyrocare Technologies Ltd. | 1.94% | 1.76% | -0.19% |
| Pfizer Ltd. | 1.19% | 1.01% | -0.18% |
| Shilpa Medicare Ltd. | 1.27% | 1.43% | +0.16% |
| Lupin Ltd. | 3.10% | 2.94% | -0.16% |
| Ajanta Pharma Ltd. | 4.22% | 4.35% | +0.12% |
| Jubilant Pharmova Ltd. | 0.50% | 0.60% | +0.10% |
| CORONA Remedies Ltd. | 2.17% | 2.27% | +0.10% |
| Dr. Reddy's Laboratories Ltd. | 1.04% | 1.13% | +0.10% |
| Vinati Organics Ltd. | 0.77% | 0.69% | -0.08% |
| Suraksha Diagnostic Ltd. | 1.03% | 1.10% | +0.08% |
| Metropolis Healthcare Ltd. | 1.55% | 1.48% | -0.07% |
| Gland Pharma Ltd. | 2.63% | 2.70% | +0.07% |
| Sanofi Consumer Healthcare India Ltd. | 1.18% | 1.11% | -0.07% |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.90% | 0.83% | -0.06% |
| Max Healthcare Institute Ltd. | 0.66% | 0.60% | -0.06% |
| Manipal Health Enterprises Ltd. | 1.12% | 1.07% | -0.06% |
| Medi Assist Healthcare Services Ltd. | 0.78% | 0.73% | -0.05% |
| Syngene International Ltd. | 0.69% | 0.64% | -0.05% |
| Vijaya Diagnostic Centre Ltd. | 1.08% | 1.04% | -0.03% |
| Procter & Gamble Health Ltd. | 1.84% | 1.82% | -0.02% |
| Anthem Biosciences Ltd. | 1.15% | 1.13% | -0.02% |
| Piramal Pharma Ltd. | 1.24% | 1.22% | -0.02% |
| Aurobindo Pharma Ltd. | 4.53% | 4.52% | -0.02% |
| Alkem Laboratories Ltd. | 1.69% | 1.68% | -0.01% |
| Divi's Laboratories Ltd. | 2.23% | 2.24% | +0.01% |
| Natco Pharma Ltd. | 0.92% | 0.92% | +0.01% |
| Ipca Laboratories Ltd. | 2.71% | 2.71% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,934 Cr | 1.89% | 36.5% | 20.8% | 21.6% |
 SBI Healthcare Opportunities Fund | ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Fund managers
- Dhaval ShahMr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months11.58% absolute | ₹60,000 | ₹66,948 | 11.58% | |
| 1 year19.38% annualised | ₹1,20,000 | ₹1,33,374 | 11.14% | |
| 3 years19.35% annualised | ₹3,60,000 | ₹4,90,687 | 36.30% | |
| 5 years14.32% annualised | ₹6,00,000 | ₹8,79,854 | 46.64% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of Aditya Birla Sun Life Pharma & Healthcare Fund?
The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund is ₹37.20 as on 9 Nov 2026.
What is the expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund?
The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund is 2.29% per year.
What is the minimum SIP amount for Aditya Birla Sun Life Pharma & Healthcare Fund?
You can start a SIP in Aditya Birla Sun Life Pharma & Healthcare Fund with ₹3,000 a month.
What returns has Aditya Birla Sun Life Pharma & Healthcare Fund given?
Aditya Birla Sun Life Pharma & Healthcare Fund has returned 26.1% over 1 year, 15.3% over 3 years and 18.4% over 5 years (annualised).
Is there a lock-in or exit load on Aditya Birla Sun Life Pharma & Healthcare Fund?
Lock-in: None. Exit load: Exit load of 1% if redeemed within 30 days..
How risky is Aditya Birla Sun Life Pharma & Healthcare Fund?
Aditya Birla Sun Life Pharma & Healthcare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages Aditya Birla Sun Life Pharma & Healthcare Fund?
Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Aditya Birla Sun Life Mutual Fund, which runs 86 schemes with ₹4,46,664 Cr under management.